NBY Live-Signale | Maximieren Sie Profite mit Getagraph.com

Live Chart Being Loaded With Signals

Commentary (17 Mai 2024 @ 22:00):

Stats
Tagesvolumen	133.28M
Durchschnittsvolumen	5.07M
Marktkapitalisierung	4.49M
EPS	$0 ( 2024-05-09 )
Nächstes Ertragsdatum	( $-0.150 ) 2024-05-28
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0300
ATR14	$0.00100 (0.84%)

Insider Trading

Date	Person	Action	Amount	type
2023-06-09	Freiman Paul E.	Buy	858	Restricted Stock Units
2023-06-09	Garlikov Julie	Buy	858	Restricted Stock Units
2023-06-09	Zheng Yenyou	Buy	858	Restricted Stock Units
2023-06-09	Zheng Yongxiang	Buy	858	Restricted Stock Units
2023-06-09	Sit Swan	Buy	858	Restricted Stock Units

INSIDER POWER
-62.74
Last 96 transactions
Buy: 2 335 940 \| Sell: 2 184 002

Volumen Korrelation

Lang: -0.22 (neutral)

Kurz: -0.16 (neutral)

Signal:(53.018) Neutral

NovaBay Pharmaceuticals Korrelation

10 Am meisten positiv korreliert

10 Am meisten negativ korreliert

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

NovaBay Pharmaceuticals Korrelation - Währung/Rohstoff

0.00
( neutral )

-0.45
( neutral )

0.00
( neutral )

0.79
( moderate )

NovaBay Pharmaceuticals Finanzdaten

Annual	2023
Umsatz:	$14.73M
Bruttogewinn:	$7.90M (53.61 %)
EPS:	$-2.29

FY	2023
Umsatz:	$14.73M
Bruttogewinn:	$7.90M (53.61 %)
EPS:	$-2.29

FY	2022
Umsatz:	$14.40M
Bruttogewinn:	$7.78M (54.02 %)
EPS:	$-10.10

FY	2021
Umsatz:	$8.42M
Bruttogewinn:	$5.65M (67.03 %)
EPS:	$-9.42

Financial Reports:

No articles found.

NovaBay Pharmaceuticals Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

NovaBay Pharmaceuticals

NovaBay Pharmaceuticals, Inc., a pharmaceutical company, develops and sells eyecare and skincare products in the United States and internationally. It offers Avenova, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products under the NeutroPhase and PhaseOne brands. The company also provides dermatological solutions to address skincare concerns comprising keratosis pilaris, rosacea and eczema, anti-aging, SPF, hyperhidrosis, excessive hair, and acne under the DERMAdoctor brand. It sells its products through retailers, digital beauty channels, and distributors, as well as online. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.